Ngā hua rapu kaituhi

1

Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer mā Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, L. T. Busund, Roy M. Bremnes

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Prognostic Impact of Fibroblast Growth Factor 2 in Non-small Cell Lung Cancer: Coexpression with VEGFR-3 and PDGF-B Predicts Poor Survival mā Tom Dønnem, Khalid Al‐Shibli, Samer Al‐Saad, Lill‐Tove Busund, Roy M. Bremnes

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer mā Samer Al‐Saad, Khalid A. Alshibli, Tom Dønnem, Magnus Persson, Bremnes Rm, Busund Lt

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Combination of low vascular endothelial growth factor A (VEGF‐A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor... mā Tom Dønnem, Khalid Al‐Shibli, Sigve Andersen, Samer Al‐Saad, Lill‐Tove Busund, Roy M. Bremnes

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells mā Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Lill‐Tove Busund, Roy M. Bremnes

I whakaputaina 2008

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer mā Khalid Al‐Shibli, Tom Dønnem, Samer Al‐Saad, Magnus Persson, Roy M. Bremnes, Lill‐Tove Busund

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival mā Sigve Andersen, Tom Dønnem, Helge Stenvold, Samer Al‐Saad, Khalid A. Alshibli, Lill‐Tove Busund, Roy M. Bremnes

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Cancer-Associated Fibroblasts from Lung Tumors Maintain Their Immunosuppressive Abilities after High-Dose Irradiation mā Laia Gorchs, Turid Hellevik, Jack‐Ansgar Bruun, Ketil-Andre Camilio, Samer Al‐Saad, Tor B. Stuge, Iñigo Martínez-Zubiaurre

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy mā Sigurd M. Hald, Roy M. Bremnes, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Lill‐Tove Busund, Tom Dønnem

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer mā Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund

I whakaputaina 2010

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer mā Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund

I whakaputaina 2010

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non–Small Cell Lung Cancer mā Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Marit Pedersen Delghandi, Magnus Persson, Marit N. Nilsen, Lill‐Tove Busund, Roy M. Bremnes

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers mā Thomas K. Kilvaer, Mehrdad Rakaee, Turid Hellevik, Samer Al‐Saad, Erna‐Elise Paulsen, Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Iñigo Martínez

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer mā Mehrdad Rakaee, Lill‐Tove Busund, Erna‐Elise Paulsen, Elin Richardsen, Samer Al‐Saad, Sigve Andersen, Tom Dønnem, Roy M. Bremnes, Thomas K. Kilvaer

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure mā Thea Grindstad, Sigve Andersen, Samer Al‐Saad, Tom Dønnem, Yury Kiselev, Christian Melbø‐Jørgensen, Kaja Skjefstad, Lill‐Tove Busund, Roy M. Bremnes, Elin Richardsen

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression mā Thea Grindstad, Elin Richardsen, Sigve Andersen, Kaja Skjefstad, Mehrdad Rakaee, Tom Dønnem, Nora Ness, Yngve Nordby, Roy M. Bremnes, Samer Al‐Saad, Lill‐Tove Busund

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival mā Marte Eilertsen, Sigve Andersen, Samer Al‐Saad, Yury Kiselev, Tom Dønnem, Helge Stenvold, Ingvild Pettersen, Khalid Al‐Shibli, Elin Richardsen, Lill‐Tove Busund, Roy M. Bremnes

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry mā Mehrdad Rakaee, Lill-Tove Rasmussen Busund, Simin Jamaly, Erna‐Elise Paulsen, Elin Richardsen, Sigve Andersen, Samer Al‐Saad, Roy M. Bremnes, Tom Dønnem, Thomas K. Kilvaer

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer mā Tom Dønnem, Kenneth Lønvik, Katrine Eklo, Thomas Berg, Sveinung Wergeland Sørbye, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Roy M. Bremnes, Lill‐Tove Busund

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer mā Tom Dønnem, Christopher G. Fenton, Kenneth Lønvik, Thomas Berg, Katrine Eklo, Sigve Andersen, Helge Stenvold, Khalid Al‐Shibli, Samer Al‐Saad, Roy M. Bremnes, Lill‐Tove Busund

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Samer Al‐Saad

Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer mā Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, L. T. Busund, Roy M. Bremnes

Prognostic Impact of Fibroblast Growth Factor 2 in Non-small Cell Lung Cancer: Coexpression with VEGFR-3 and PDGF-B Predicts Poor Survival mā Tom Dønnem, Khalid Al‐Shibli, Samer Al‐Saad, Lill‐Tove Busund, Roy M. Bremnes

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer mā Samer Al‐Saad, Khalid A. Alshibli, Tom Dønnem, Magnus Persson, Bremnes Rm, Busund Lt

Combination of low vascular endothelial growth factor A (VEGF‐A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor... mā Tom Dønnem, Khalid Al‐Shibli, Sigve Andersen, Samer Al‐Saad, Lill‐Tove Busund, Roy M. Bremnes

Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells mā Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Lill‐Tove Busund, Roy M. Bremnes

Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer mā Khalid Al‐Shibli, Tom Dønnem, Samer Al‐Saad, Magnus Persson, Roy M. Bremnes, Lill‐Tove Busund

Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival mā Sigve Andersen, Tom Dønnem, Helge Stenvold, Samer Al‐Saad, Khalid A. Alshibli, Lill‐Tove Busund, Roy M. Bremnes

Cancer-Associated Fibroblasts from Lung Tumors Maintain Their Immunosuppressive Abilities after High-Dose Irradiation mā Laia Gorchs, Turid Hellevik, Jack‐Ansgar Bruun, Ketil-Andre Camilio, Samer Al‐Saad, Tor B. Stuge, Iñigo Martínez-Zubiaurre

CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy mā Sigurd M. Hald, Roy M. Bremnes, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Lill‐Tove Busund, Tom Dønnem

The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer mā Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund

Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non–Small Cell Lung Cancer mā Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Marit Pedersen Delghandi, Magnus Persson, Marit N. Nilsen, Lill‐Tove Busund, Roy M. Bremnes

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers mā Thomas K. Kilvaer, Mehrdad Rakaee, Turid Hellevik, Samer Al‐Saad, Erna‐Elise Paulsen, Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Iñigo Martínez

Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer mā Mehrdad Rakaee, Lill‐Tove Busund, Erna‐Elise Paulsen, Elin Richardsen, Samer Al‐Saad, Sigve Andersen, Tom Dønnem, Roy M. Bremnes, Thomas K. Kilvaer

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure mā Thea Grindstad, Sigve Andersen, Samer Al‐Saad, Tom Dønnem, Yury Kiselev, Christian Melbø‐Jørgensen, Kaja Skjefstad, Lill‐Tove Busund, Roy M. Bremnes, Elin Richardsen

Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression mā Thea Grindstad, Elin Richardsen, Sigve Andersen, Kaja Skjefstad, Mehrdad Rakaee, Tom Dønnem, Nora Ness, Yngve Nordby, Roy M. Bremnes, Samer Al‐Saad, Lill‐Tove Busund

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival mā Marte Eilertsen, Sigve Andersen, Samer Al‐Saad, Yury Kiselev, Tom Dønnem, Helge Stenvold, Ingvild Pettersen, Khalid Al‐Shibli, Elin Richardsen, Lill‐Tove Busund, Roy M. Bremnes

Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer mā Tom Dønnem, Kenneth Lønvik, Katrine Eklo, Thomas Berg, Sveinung Wergeland Sørbye, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Roy M. Bremnes, Lill‐Tove Busund

MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer mā Tom Dønnem, Christopher G. Fenton, Kenneth Lønvik, Thomas Berg, Katrine Eklo, Sigve Andersen, Helge Stenvold, Khalid Al‐Shibli, Samer Al‐Saad, Roy M. Bremnes, Lill‐Tove Busund

Ngā utauta rapu:

Ngā marau whai pānga